Disease Proof

Gardasil Denied Approval for Women 27 to 45, Again!

For the second time, U.S. health regulators have denied approval for the use of Gardasil in women, ages 27 to 45. Officials want more long term clinical data. Merck’s Gardasil is said to protect against human papillomavirus (HPV), which can cause cervical cancer. Following the denial Merck’s shares dropped 79 cents. Merck is also pushing Gardasil for use among men; Reuters reports.

Now, Gardasil is no wonder drug! The U.S. Food and Drug Administration has received 7,802 instances of people suffering an adverse reaction to Gardasil and the vaccine only protects against 4 of the 100 strains of HPV. It also killed a 17-year old girl from New York. Not to mention, this spring the FDA ordered Merck clean up a manufacturing plant where Gardasil is produced.

Image credit: christopherdale

Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (1) Read through and enter the discussion with the form at the end
Denise Melton - January 23, 2009 10:36 AM

It was so refreshing to hear someone tell Merck to "clean up their act" To set the story straight there have been 35 deaths and 15,000 adverse reactions to the Gardasil vaccine that have been reported. There are hundreds maybe thousands that have not been reported. I lost my granddaughter to that vaccine. She was the one in New York State. Lets keep after Merck until they have to pull Gardasil off the market. Lets save the lives of our girls and stop the madness Gardasil is creating.

Dr. Fuhrman's Executive Offices
4 Walter E. Foran Blvd.
Suite 408
Flemington, NJ 08822